Keyhole limpet hemocyanin-derived peptide-MHC class II complex (KLH-peptide-MHC-II)

Keyhole limpet hemocyanin (KLH) is a high-molecular-weight, copper-containing metalloprotein derived from the hemolymph of the giant keyhole limpet, Megathura crenulata (Harris & Markl, 1999). It is recognized as a potent immunogen in humans and is frequently employed as a carrier protein for haptens and weakly immunogenic antigens to enhance immune responses (Swaminathan et al., 2014). When administered, dendritic cells (DCs) internalize KLH, process it through the endocytic pathway, and present the resulting peptides on MHC class II molecules to CD4+ T helper cells (Lebrecht et al., 2009). This presentation is critical for the induction of both cellular and humoral immunity, making the KLH-peptide-MHC II complex a vital component in the development of conjugate vaccines and the assessment of patient immunocompetence (Geyer et al., 2005). In clinical oncology, KLH is used as an adjuvant in dendritic cell-based vaccines to provide T-cell help and as a tracer to monitor the efficacy of antigen presentation (ClinicalTrials.gov, NCT00003889). Furthermore, KLH itself is used as an intravesical treatment for superficial bladder cancer, where it stimulates a local immune response against tumor cells (Lamm et al., 1982). The complex is also a target for monitoring the success of DC maturation and migration in vivo. While generally safe, the primary therapeutic challenge involves managing potential hypersensitivity reactions in sensitized individuals.

Other names

KLH-MHC II complexKLH-derived epitopesKeyhole limpet hemocyanin antigenKLH-peptide-HLA-DR complex

Presentation of exogenous KLH-derived peptides by MHC class II molecules on the surface of dendritic cells to the T-cell receptor (TCR) of CD4+ T helper cells, inducing a robust cellular and humoral immune response.